COSCIENS Biopharma Inc.
CSCI.TO
TSX
| 12/31/2024 | 06/30/2024 | 03/31/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 145.48% | -34.09% | -36.54% | -36.54% | -86.81% |
| Total Receivables | 752.07% | 38.69% | -84.65% | -84.65% | -86.57% |
| Inventory | -32.88% | 3,184.95% | -71.81% | -71.81% | 1,650.66% |
| Prepaid Expenses | 1,998.77% | -99.85% | -33.23% | -33.23% | -81.07% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 247.37% | -- | -- | -- | -89.85% |
| Total Current Assets | 112.84% | -27.64% | -38.48% | -38.48% | -79.69% |
|
|
|||||
| Total Current Assets | 112.84% | -27.64% | -38.48% | -38.48% | -79.69% |
| Net Property, Plant & Equipment | -5.83% | 4,239.25% | 9.27% | 9.27% | 5,291.20% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -100.00% | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -85.11% | 516.31% | 0.00% | 0.00% | 156.52% |
| Total Assets | 47.69% | 7.66% | -38.01% | -38.01% | -57.62% |
|
|
|||||
| Total Accounts Payable | 756.58% | -- | -- | -- | -86.21% |
| Total Accrued Expenses | 224.35% | -- | -- | -- | -59.16% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -9.36% | 180.69% | 14.93% | 14.93% | 162.28% |
| Total Finance Division Other Current Liabilities | -- | -7.17% | -87.57% | -87.57% | -- |
| Total Other Current Liabilities | -- | -7.17% | -87.57% | -87.57% | -- |
| Total Current Liabilities | 450.88% | 142.78% | -18.37% | -18.37% | -81.39% |
|
|
|||||
| Total Current Liabilities | 450.88% | 142.78% | -18.37% | -18.37% | -81.39% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 45.75% | 1,405.88% | 5.26% | 5.26% | 2,052.31% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -4.55% | -0.55% | -0.55% | -- |
| Total Liabilities | 708.45% | 36.85% | -6.24% | -6.24% | -86.62% |
|
|
|||||
| Common Stock & APIC | 66.35% | -92.50% | 0.00% | 0.00% | -96.48% |
| Retained Earnings | -378.01% | 100.43% | -5.26% | -5.26% | 101.24% |
| Treasury Stock & Other | -11.92% | -97.15% | 0.56% | 0.56% | -23.22% |
| Total Common Equity | -37.43% | -9.81% | -58.44% | -58.44% | -41.20% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -37.43% | -9.81% | -58.44% | -58.44% | -41.20% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -37.43% | -9.81% | -58.44% | -58.44% | -41.20% |
|
|
|||||